Feature

What’s Driving the Higher Breast Cancer Death Rate in Black Women?


 

More women today are surviving breast cancer if it’s caught early, largely because of better screening and more effective and targeted treatments.

However, not everyone has benefited equitably from this progress. Critical gaps in breast cancer outcomes and survival remain for women in racial and ethnic minority groups.

Black women for instance, have a 41% higher death rate from breast cancer compared with White patients. They also have a greater incidence of aggressive disease like triple-negative breast cancer. Native American and Hispanic women, meanwhile, are more likely to be diagnosed with breast cancer at an earlier age than White women and experience more aggressive breast cancers.

In 2023, Farhad Islami, MD, PhD, and his team published an updated analysis of racial/ethnic and socioeconomic disparities in cancer trends based on data from 2014 to 2020. The analysis found that Black women in particular, were the least likely to have an early-stage diagnosis of breast cancer. Localized‐stage breast cancer was diagnosed in 57% of Black women versus 68% of White women.

Farhad Islami, MD, PhD, senior scientific director of cancer disparity research in the Surveillance & Health Equity Science Department at the American Cancer Society American Cancer Society

Dr. Farhad Islami

“Despite substantial progress in cancer prevention, early detection, and treatments, the burden of cancer remains greater among populations that have been historically marginalized, including people of color, people with lower socioeconomic status, and people living in nonmetropolitan areas,” said Dr. Islami, who is senior scientific director of cancer disparity research in the Surveillance & Health Equity Science Department at the American Cancer Society.

The reasons behind outcomes disparities in breast cancer are complex, making solutions challenging, say experts researching racial differences in cancer outcomes.

While social determinants of health (SDH) seem to be drivers of higher breast cancer mortality in Black women, biological differences between Black and White women are also linked to poorer outcomes in Black women with breast cancer, new studies suggest. Among the findings of this research is that breast cancer tests may be contributing to the disparities and misguiding care for some patients of color.

SDH and Screening Rates Differences By Race

A range of factors contribute to racial and ethnic disparities in breast cancer outcomes, said Pamela Ganschow, MD, an associate professor in the Department of Internal Medicine at the University of Illinois Cancer Center in Chicago and part of the university’s Cancer Prevention and Control research program. These include socioeconomic status, access to timely and high-quality care across the cancer control continuum, cultural beliefs, differences in genetic makeup and tumor biology, as well as system biases, such as implicit biases and systemic racism, Dr. Ganschow said.

Dr. Islami adds that gaps in access to cancer prevention, early detection, and treatment are largely rooted in fundamental inequities in social determinants of health (SDH), such as whether a patient has safe housing, transportation, education, job opportunities, income, access to nutritious foods, and language and literacy skills, among others.

Dr. Islami’s analysis, for example, shows that people of color are generally more likely to have lower educational attainment and to experience poverty, food insecurity, and housing insecurity compared with White people. Among people aged 18-64 years, the age-adjusted proportion of individuals with no health insurance in 2021 was also higher among Black (13.7%), American Indian/Alaskan Native (18.7%), and Hispanic (28.7%) patients than among White (7.8%) or Asian (5.9%) people, according to the report.

Competing needs can also get in the way of prioritizing cancer screenings, especially for patients in lower socio-economic populations, Dr. Ganschow said.

Pamela Ganschow, MD, associate professor in the Department of Internal Medicine at the University of Illinois Cancer Center in Chicago University of Illinois Cancer Center

Dr. Pamela Ganschow

“You’ve got people who are working a job or three jobs, just to make ends meet for their family and can’t necessarily take time off to get that done,” she said. “Nor is it prioritized in their head because they’ve got to put a meal on the table.”

But the racial disparities between Black and White women, at least, are not clearly explained by differences between the screening rates..

Of patients who received mammograms 76% were White and 79% were Black, according to another recent study coauthored by Dr. Islami. While Black women appear to have the highest breast cancer screening rates, some data suggest such rates are being overreported.

Lower screening rates were seen in American Indian/Alaska Native (59%), Asian (67%), and Hispanic women (74%).

Pages

Recommended Reading

High TIL Levels Linked to Improved Prognosis in Early TNBC Even in Absence of Chemotherapy
MDedge Hematology and Oncology
Novel Treatment Sequence Speeds Up Breast Reconstruction Procedures in Patients With Breast Cancer
MDedge Hematology and Oncology
MRI-Based Strategy Can Limit Neoadjuvant Chemotherapy Duration in HR−/HER2+ BC
MDedge Hematology and Oncology
Breast Cancer Radiation Therapy Raises Risk for Nonkeratinocyte Skin Cancer
MDedge Hematology and Oncology
Antibiotic Exposure During Immunotherapy Increases Disease Burden in HER2− Early BC
MDedge Hematology and Oncology
Adjuvant Chemotherapy May be Omitted in Older Women Aged 80 Years or Older With HR+/HER2- BC
MDedge Hematology and Oncology
Impact of Adjuvant Ovarian Function Suppression on Recurrence Risk in Premenopausal HR+ Breast Cancer
MDedge Hematology and Oncology
Hormone + Radiation Therapy Better Than Either Treatment in Older Men With Early HR+ BC
MDedge Hematology and Oncology
Most Targeted Cancer Drugs Lack Substantial Clinical Benefit
MDedge Hematology and Oncology
Certain Women May Face Higher Risk for Second Breast Cancer
MDedge Hematology and Oncology